Acorda Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Acorda Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Acorda Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $130K, a 83.1% increase year-over-year.
  • Acorda Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $537K, a 50.4% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $478K, a 68% decline from 2022.
  • Acorda Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.5M, a 50.1% decline from 2021.
  • Acorda Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3M, a 63% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $478K -$1.02M -68% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $1.5M -$1.5M -50.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $3M -$5.11M -63% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $8.1M -$6.15M -43.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 $14.3M -$7M -32.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $21.3M -$11.6M -35.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 $32.8M -$3.57M -9.82% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $36.4M +$2.92M +8.73% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $33.5M +$4.03M +13.7% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
2014 $29.4M +$4.3M +17.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $25.1M +$3.72M +17.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $21.4M +$2.12M +11% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $19.3M +$1.53M +8.58% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 $17.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.